-
Local recurrence in primary localised resected gastrointestinal stromal tumours: A registry observational national cohort study including 912 patients2023 European Journal of Cancer article Medicine Gastrointestinal Tumor Research and Treatment Open access
Roos F. Bleckman, Evelyne Roets, Nikki S. IJzerman, Mohammed Mohammadi, Han J. Bonenkamp, Hans A. J. Gelderblom, +4 more
7citations -
External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer2023 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Yuwei Wang, Annegien Broeks, Daniele Giardiello, Michael Hauptmann, Katarzyna Jóźwiak, Esther A. Koop, +13 more
6citations -
10-year survival after resection of pancreatic ductal adenocarcinoma with pathological re-examination of a nationwide cohort2025 European Journal of Cancer article Medicine Pancreatic and Hepatic Oncology Research Open access
Eva M M Verkolf, Esther N. Dekker, Lydia G. van der Geest, Marc G. Besselink, Bert A. Bonsing, Marco J. Bruno, +11 more
6citations -
Adjuvant capecitabine versus nihil in older patients with node-positive/high-risk node-negative early breast cancer receiving ibandronate – The ICE randomized clinical trial2023 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Marcus Schmidt, Ulrike Anneliese Nitz, Toralf Reimer, Sabine Schmatloch, Heiko Graf, Marianne Just, +10 more
5citations -
Disease-free survival as surrogate for overall survival in esophageal cancer: An individual patient data meta-analysis of neoadjuvant chemotherapy and chemoradiotherapy2025 European Journal of Cancer review Medicine Esophageal Cancer Research and Treatment Open access
Nicolas Cabrit, Armel Maurice Cheugoua-Zanetsie, Jayne F. Tierney, Pierre Guillame Thirion, Matthew Guy Nankivell, Kathryn A Winter, +27 more
5citations -
Cost-effectiveness of treatment sequences for BRAF-mutant advanced melanoma in the Netherlands using a health economic model2024 European Journal of Cancer article Economics, Econometrics and Finance Health Systems, Economic Evaluations, Quality of Life Open access
Hedwig M. Blommestein, Saskia de Groot, Brenda Leeneman, Carin A. Uyl‐de Groot, John B.A.G. Haanen, Michel W.J.M. Wouters, +12 more
5citations -
Shared decision-making supported by outcome information regarding surveillance after curative treatment for breast cancer: Results of the SHOUT-BC study2024 European Journal of Cancer article Health Professions Patient-Provider Communication in Healthcare Open access
Jet Wies Ankersmid, Constance H.C. Drossaert, Luc J. A. Strobbe, Mariska Q.N. Hackert, Noel Engels, Janine C. M. Prick, +5 more
5citations -
Patient-led follow-up after curative colorectal cancer surgery: The primary outcome analysis of the prospective, multicentre FUTURE-primary implementation study
M. H. Elise van Driel, Lissa Wullaert, Kelly R. Voigt, Loubna Outmani, Pascal Gabriël Doornebosch, Koen C.M.J. Peeters, +6 more
4citations -
Conference on challenges in sarcoma (CCS) 2024: Expert opinions on non-evidence-based management aspects2025 European Journal of Cancer article Medicine Sarcoma Diagnosis and Treatment Open access cited by 1 patent
Silvia Höfer, Chantal Pauli, Beata Bode‐Lesniewska, Sylvie Bonvalot, Christina Fotopoulou, Hans A. J. Gelderblom, +24 more
4citations -
Adjustment for imbalances in baseline characteristics in the MAGNITUDE phase 3 study confirms the clinical benefit of niraparib in combination with abiraterone acetate plus prednisone in patients with metastatic prostate cancer
Guilhem Roubaud, Gerhardt Attard, Martin Boegemann, David Olmos, Marco Trevisan, Laurent Antoni, +6 more
4citations -
CNS infections in patients with hematological or oncological diseases (including cellular therapies) – 2024 update of the guideline of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)
Rehsan Akdas, Enrico Schalk, Jannik Stemler, Stefan Schwartz, Uta Meyding‐Lamadé, Jens Panse, +9 more
3citations -
Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sophie C. Hagenaars, S de Groot, Danielle B. Cohen, Ayoub Charehbili, Tim J. A. Dekker, Elma Meershoek‐Klein Kranenbarg, +6 more
3citations -
Pharmacokinetics and pharmacodynamics of an anti-CSF1 receptor antibody in the intra-articular treatment of tenosynovial giant cell tumor2025 European Journal of Cancer article Medicine Musculoskeletal synovial abnormalities and treatments Open access
Michiel A. J. van de Sande, Kirk W. Johnson, Kirsten van Langevelde, Thomas J. Scharschmidt, Laman Alani, Dorothy Nguyen, +3 more
3citations -
De-escalating treatment for low-risk Ductal Carcinoma In Situ: Early safety of active surveillance without endocrine therapy in the prespecified interim analysis of the LORD-trial* (BOOG 2014-04)2026 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
J. Wesseling, M. Nieberg, S. Aleikhaneshir, Lotte E. Elshof, R. Schmitz, Carine Sondermeijer, +13 more
3citations